Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man

被引:30
作者
Iversen, PL [1 ]
Copple, BL [1 ]
Tewary, HK [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,EPPLEY INST RES CANC,DEPT PHARMACEUT SCI,OMAHA,NE 68198
关键词
phosphorothioate oligonucleotides; preclinical pharmacology; DNA damage; p53; mRNA; gene-specific therapeutics;
D O I
10.1016/0378-4274(95)03572-9
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Phosphorothioate oligonucleotides (PS-ODN) designed to temporarily modulate selected gene expression have made the journey from bench top to bedside in a remarkably short period of time. A PS-ODN with sequence complementary to the p53 mRNA was administered to mice (4 mg/kg subcutaneously), rats (3-300 mg/kg intravenously), monkeys (intravenous infusions for up to 15 days) and humans (up to 0.25 mg/kg/h intravenous infusions for 10 days). These studies demonstrate the PS-ODN provides feasible pharmacokinetic parameters and minimal toxicity.
引用
收藏
页码:425 / 430
页数:6
相关论文
共 40 条